H.C. Wainwright reiterates Eton Pharmaceuticals Inc (ETON) rating to a Buy

Eton Pharmaceuticals Inc’s filing revealed that its Chief Business Officer Krempa David unloaded Company’s shares for reported $0.25 million on Jun 12 ’25. In the deal valued at $14.92 per share,16,977 shares were sold. As a result of this transaction, Krempa David now holds 629,669 shares worth roughly $9.95 million.

Then, Krempa David sold 10,223 shares, generating $150,585 in total proceeds. Upon selling the shares at $14.73, the Chief Business Officer now owns 612,646 shares.

Before that, Krempa David sold 6,800 shares. Eton Pharmaceuticals Inc shares valued at $100,436 were divested by the Chief Business Officer at a price of $14.77 per share. As a result of the transaction, Krempa David now holds 622,869 shares, worth roughly $9.84 million.

H.C. Wainwright reiterated its Eton Pharmaceuticals Inc [ETON] rating to a Buy in a research note published on January 23, 2025; the price target was $33. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering ETON and reiterated its “Buy” recommendation on January 06, 2025.

Price Performance Review of ETON

On Tuesday, Eton Pharmaceuticals Inc [NASDAQ:ETON] saw its stock jump 9.80% to $15.8. Over the last five days, the stock has gained 10.88%. Eton Pharmaceuticals Inc shares have risen nearly 380.24% since the year began. Nevertheless, the stocks have risen 18.62% over the past one year. While a 52-week high of $21.48 was reached on 05/14/25, a 52-week low of $3.25 was recorded on 04/07/25.

Levels Of Support And Resistance For ETON Stock

The 24-hour chart illustrates a support level at 14.88, which if violated will result in even more drops to 13.96. On the upside, there is a resistance level at 16.32. A further resistance level may holdings at 16.83.

How much short interest is there in Eton Pharmaceuticals Inc?

A steep rise in short interest was recorded in Eton Pharmaceuticals Inc stocks on 2025-06-13, growing by 0.53 million shares to a total of 1.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.59 million shares. There was a rise of 47.38%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on May 06, 2024 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.